Pharmafile Logo
Pharmafocus logo
Advanced Search
Roche's Avastin (bevacizumab)

Avastin’s breast cancer use to continue in Europe

March 2, 2011
Sales and Marketing CHMP, Cancer, European Commission, Roche, avastin, bevacizumab, breast cancer, docetaxel, paclitaxel

Roche’s Avastin will remain on the market as a treatment for breast cancer, but only in combination with paclitaxel, the …

News

GlaxoSmithKline seeks alliances with ‘academic superstars’

March 2, 2011
Research and Development GSK, GlaxoSmithKline, Pentraxin Therapeutics, academia, al Free and University College Medical School, universities

GlaxoSmithKline has unveiled a partnership with a ‘superstar academic’, as part of a new strategy which it believes will help …

News

Daiichi Sankyo gains rights to potential blockbuster cancer drug

March 2, 2011
Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …

News

Samsung forges biosimilar venture with Quintiles

March 2, 2011
Manufacturing and Production Quintiles, Samsung, biosimilar production, biosimilars, pharma production

South Korean electronics giant Samsung has formed a joint venture with Quintiles with the objective of breaking into the market …

News

Fujifilm buys into bio with Merck acquisitions

March 2, 2011
Manufacturing and Production Biomanufacturing, Fujifilm, Merck, Merck & Co, Merck/MSD Biomanufacturing Network, contract manufacturing

Japanese photography and imaging company Fujifilm continued its diversification into other sectors with the acquisition of the Merck/MSD Biomanufacturing Network, …

News
Bayer's Marijn Dekkers

Bayer goes for pharma growth

March 1, 2011
Research and Development, Sales and Marketing 2010 pharma results, Bayer, Dr Jörg Reinhardt, Marijn Dekkers, Nexavar, VEGF Trap-Eye, Xarelto

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …

Feature

Pfizer drops 15 pipeline projects

March 1, 2011
Research and Development Lyrica, Pfizer, Pfizer R&D, Pfizer product pipeline, Pfizer research, inotuzumab, pregabalin

Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …

News

LEO Pharma Selects Veeva CRM for Pan-European Deployments

March 1, 2011
Sales and Marketing veeva

BARCELONA, SPAIN — 1 March, 2011 – LEO Pharma, a leading global pharmaceutical company specialising in dermatology and critical care, …

News
Press release

Dutch government sells off vaccine facility

March 1, 2011
Manufacturing and Production Bilthoven, Holland, NVI, Netherlands, Netherlands Vaccine Institute, vaccine manfacturing, vaccine production, vaccines

The Dutch government has put the manufacturing activities and capacity of the Netherlands Vaccine Institute in Bilthoven up for sale, …

News

Catalent sells off printed components business

March 1, 2011
Manufacturing and Production Catalent, Clondalkin, pharma packaging, pharmaceutical packaging

Catalent Pharma Solutions has agreed to sell its printed components business to Dutch packaging giant Clondalkin, which has been steadily …

News

Nampak to leave Portsmouth for new facility

March 1, 2011
Manufacturing and Production Nampak Healthcare, Portsmouth, Segensworth, pharma packaging, pharmaceutical carton facility

Nampak Healthcare plans to invest in a new manufacturing facility in Segensworth, UK, to overcome the limitations of its current …

News

Friedhelm Felten to head procurement at Merck

March 1, 2011
Manufacturing and Production, Research and Development Friedhelm Felten, Merck KGaA, appointment, manufacturing and production, research and development

Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …

Appointment

Forest depression candidate struggles against placebo

March 1, 2011
Research and Development Forest, Forest Laboratories, Gedeon Richter, cariprazine, depression, major depressive disorder

An investigational antipsychotic drug being developed by Forest Laboratories and Budapest-based Gedeon Richter has failed to prove itself in phase …

News

Pfizer in break up talks for Sandwich research site

March 1, 2011
Research and Development Kent, Pfizer, Sandwich, job cuts

Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …

News

Service Insight: Discovery metrics – creating the right balance

February 28, 2011
Research and Development Atkinson Cowan, Kinapse, Service Insight, metrics, research and development

SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in the pharmaceutical industry over the …

Feature
viiv_gsk_pfizer_david_redfern

David Redfern appointed ViiV chairman

February 28, 2011
Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing

David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.

Appointment
black_swan_luke_mcdermott

Black Swan Analysis appoints Luke McDermott

February 28, 2011
Sales and Marketing Black Swan Analysis, Luke McDermott, appointment, sales and marketing

Maidenhead, UK-based Black Swan Analysis has expanded its analysis and forecasting team with the appointment of Luke McDermott.He joins the …

Appointment

AZ opens new global HQ in London

February 28, 2011
Medical Communications, Sales and Marketing AZ, AstraZeneca, London

AstraZeneca has moved its London global headquarters from Mayfair to new, larger premises in Paddington. The new offices are located …

News

Healthcare IT and patients: lessons from the NHS experience

February 28, 2011
Medical Communications, Sales and Marketing Healthcare IT, NHS, NHS IT, electronic patient records, online health information

Many countries are investing heavily in electronic health records and health information exchange to drive improvements in the quality of …

Feature

Vertex’s cystic fibrosis drug shows huge promise

February 28, 2011
Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis

US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026